Literature DB >> 22453544

Single-lung transplantation in a chronic pulmonary emphysema patient with a marginal donor who was ABO blood group nonidentical but compatible.

Yoshiyuki Susaki1, Masayoshi Inoue, Masato Minami, Yasushi Shintani, Tomoyuki Nakagiri, Noriyoshi Sawabata, Meinoshin Okumura.   

Abstract

Because the number of ideal brain-dead donors is limited, active use of marginal donors is currently one of the major issues discussed in regard to lung transplantation. We report a case in which the patient underwent single-lung transplantation for chronic pulmonary emphysema. The lung came from a marginal, ABO blood group nonidentical, compatible donor. Because the donor was marginal (pneumonia in the right lung and lobar atelectasis in both lungs), all recipient candidates with ABO blood group identical declined. Thus, a nonidentical, compatible recipient had a chance to receive a lung transplant. This 49-year-old man underwent single-lung transplantation for chronic pulmonary emphysema with severe respiratory failure. He had a good postoperative clinical course.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453544     DOI: 10.1007/s11748-011-0824-y

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  10 in total

1.  A positive donor gram stain does not predict the development of pneumonia, oxygenation, or duration of mechanical ventilation following lung transplantation.

Authors:  D Weill; G C. Dey; K R. Young; G L. Zorn; L J. Early; R A. Hicks; J Kirklin; D C. McGiffin
Journal:  J Heart Lung Transplant       Date:  2001-02       Impact factor: 10.247

2.  Guidelines for donor lung selection: time for revision?

Authors:  Karl G Reyes; David P Mason; Lucy Thuita; Edward R Nowicki; Sudish C Murthy; Gösta B Pettersson; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

3.  Marginal lung donors: A diminishing margin of safety?

Authors:  Phil Botha; Andrew J Fisher; John H Dark
Journal:  Transplantation       Date:  2006-11-27       Impact factor: 4.939

4.  The intensive care unit oxygen challenge should not be used for donor lung function decision-making.

Authors:  David C McGiffin; George L Zorn; K Randall Young; James K Kirklin; Kevin J Leon; Keith M Wille; Robert N Brown; David C Naftel; Katherine Hart; Demosthenes Lalisan
Journal:  J Heart Lung Transplant       Date:  2005-09-15       Impact factor: 10.247

5.  Influence of donor characteristics on outcome after lung transplantation: a multicenter study.

Authors:  Gabriel Thabut; Hervé Mal; Jacques Cerrina; Philippe Dartevelle; Claire Dromer; Jean-François Velly; Marc Stern; Philippe Loirat; Michelle Bertocchi; Jean-François Mornex; Alain Haloun; Philippe Despins; Christophe Pison; Daniel Blin; Gerald Simonneau; Martine Reynaud-Gaubert
Journal:  J Heart Lung Transplant       Date:  2005-09       Impact factor: 10.247

6.  Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs.

Authors:  S Sundaresan; J Semenkovich; L Ochoa; G Richardson; E P Trulock; J D Cooper; G A Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  1995-06       Impact factor: 5.209

7.  Relationship between anti-ABO antibody production and hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation.

Authors:  Y Sano; H Date; I Nagahiro; M Aoe; N Shimizu
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

8.  Extended donor lungs: eleven years experience in a consecutive series.

Authors:  Didier Lardinois; Marc Banysch; Stephan Korom; Sven Hillinger; Valentin Rousson; Annette Boehler; Rudolf Speich; Walter Weder
Journal:  Eur J Cardiothorac Surg       Date:  2005-05       Impact factor: 4.191

9.  Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation.

Authors:  B J Hunt; M Yacoub; S Amin; A Devenish; M Contreras
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

10.  Pulmonary recruitment protocol for organ donors: a new strategy to improve the rate of lung utilization.

Authors:  N Noiseux; B K Nguyen; P Marsolais; J Dupont; L Simard; I Houde; M Lallier; S Langevin; B Cantin; P Ferraro
Journal:  Transplant Proc       Date:  2009-10       Impact factor: 1.066

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.